Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reinforcing Effects of Alprazolam in Anxiety
NCT00004373Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Mar 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alprazolam in generalized anxiety disorder (GAD), panic disorder, sponsored by National Institute on Drug Abuse. Started Mar 1997; status: completed.
02
Drugs
alprazolam
03
Conditions
generalized anxiety disorder (GAD)panic disorder
Beyond the preview
Go deeper on NCT00004373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004373.